These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 32829390)

  • 21. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.
    Chao JY; Derespina KR; Herold BC; Goldman DL; Aldrich M; Weingarten J; Ushay HM; Cabana MD; Medar SS
    J Pediatr; 2020 Aug; 223():14-19.e2. PubMed ID: 32407719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials.
    Yokoyama Y; Briasoulis A; Takagi H; Kuno T
    Virus Res; 2020 Oct; 288():198137. PubMed ID: 32827627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient.
    Hillaker E; Belfer JJ; Bondici A; Murad H; Dumkow LE
    Pharmacotherapy; 2020 Jun; 40(6):592-598. PubMed ID: 32281114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
    Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
    Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.
    Moreno-Pérez O; Andres M; Leon-Ramirez JM; Sánchez-Payá J; Rodríguez JC; Sánchez R; García-Sevila R; Boix V; Gil J; Merino E
    J Autoimmun; 2020 Nov; 114():102523. PubMed ID: 32690352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
    Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
    J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
    Pandolfi L; Fossali T; Frangipane V; Bozzini S; Morosini M; D'Amato M; Lettieri S; Urtis M; Di Toro A; Saracino L; Percivalle E; Tomaselli S; Cavagna L; Cova E; Mojoli F; Bergomi P; Ottolina D; Lilleri D; Corsico AG; Arbustini E; Colombo R; Meloni F
    BMC Pulm Med; 2020 Nov; 20(1):301. PubMed ID: 33198751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
    Ader F; Bouscambert-Duchamp M; Hites M; Peiffer-Smadja N; Poissy J; Belhadi D; Diallo A; Lê MP; Peytavin G; Staub T; Greil R; Guedj J; Paiva JA; Costagliola D; Yazdanpanah Y; Burdet C; Mentré F;
    Lancet Infect Dis; 2022 Feb; 22(2):209-221. PubMed ID: 34534511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid review for the anti-coronavirus effect of remdesivir.
    Li Z; Wang X; Cao D; Sun R; Li C; Li G
    Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.
    Pereira MR; Mohan S; Cohen DJ; Husain SA; Dube GK; Ratner LE; Arcasoy S; Aversa MM; Benvenuto LJ; Dadhania DM; Kapur S; Dove LM; Brown RS; Rosenblatt RE; Samstein B; Uriel N; Farr MA; Satlin M; Small CB; Walsh TJ; Kodiyanplakkal RP; Miko BA; Aaron JG; Tsapepas DS; Emond JC; Verna EC
    Am J Transplant; 2020 Jul; 20(7):1800-1808. PubMed ID: 32330343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020 : A Cross-Sectional Study.
    Garg S; Patel K; Pham H; Whitaker M; O'Halloran A; Milucky J; Anglin O; Kirley PD; Reingold A; Kawasaki B; Herlihy R; Yousey-Hindes K; Maslar A; Anderson EJ; Openo KP; Weigel A; Teno K; Ryan PA; Monroe ML; Reeg L; Kim S; Como-Sabetti K; Bye E; Shrum Davis S; Eisenberg N; Muse A; Barney G; Bennett NM; Felsen CB; Billing L; Shiltz J; Sutton M; Abdullah N; Talbot HK; Schaffner W; Hill M; Chatelain R; Wortham J; Taylor C; Hall A; Fry AM; Kim L; Havers FP
    Ann Intern Med; 2021 Oct; 174(10):1409-1419. PubMed ID: 34370517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report.
    Gonzales-Zamora JA; Quiroz T; Vega AD
    Medwave; 2020 Aug; 20(7):e7998. PubMed ID: 32876623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19.
    Garibaldi BT; Wang K; Robinson ML; Zeger SL; Bandeen-Roche K; Wang MC; Alexander GC; Gupta A; Bollinger R; Xu Y
    JAMA Netw Open; 2021 Mar; 4(3):e213071. PubMed ID: 33760094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Trials; 2020 May; 21(1):422. PubMed ID: 32448345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies.
    Singh AK; Singh A; Singh R; Misra A
    Diabetes Metab Syndr; 2020; 14(4):641-648. PubMed ID: 32428865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
    Yang X; Yu Y; Xu J; Shu H; Xia J; Liu H; Wu Y; Zhang L; Yu Z; Fang M; Yu T; Wang Y; Pan S; Zou X; Yuan S; Shang Y
    Lancet Respir Med; 2020 May; 8(5):475-481. PubMed ID: 32105632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Audio Interview: New Data on Remdesivir in Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948
    [No Abstract]   [Full Text] [Related]  

  • 38. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19.
    Tempestilli M; Caputi P; Avataneo V; Notari S; Forini O; Scorzolini L; Marchioni L; Ascoli Bartoli T; Castilletti C; Lalle E; Capobianchi MR; Nicastri E; D'Avolio A; Ippolito G; Agrati C;
    J Antimicrob Chemother; 2020 Oct; 75(10):2977-2980. PubMed ID: 32607555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.
    Liang C; Tian L; Liu Y; Hui N; Qiao G; Li H; Shi Z; Tang Y; Zhang D; Xie X; Zhao X
    Eur J Med Chem; 2020 Sep; 201():112527. PubMed ID: 32563812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.